Cargando…

Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): study protocol for a randomized controlled trial

BACKGROUND: Inappropriate drug prescribing causes preventable drug-related adverse events that result in increased morbidity and mortality, additional costs and diminished quality of life. Numerous initiatives have been launched to improve the quality of drug prescribing and safeguard the security o...

Descripción completa

Detalles Bibliográficos
Autores principales: Correard, F., Montaleytang, M., Costa, M., Astolfi, M., Baumstarck, K., Loubière, S., Amichi, K., Auquier, P., Verger, P., Villani, P., Honore, S., Daumas, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169005/
https://www.ncbi.nlm.nih.gov/pubmed/32312242
http://dx.doi.org/10.1186/s12877-020-01546-3
_version_ 1783523761857757184
author Correard, F.
Montaleytang, M.
Costa, M.
Astolfi, M.
Baumstarck, K.
Loubière, S.
Amichi, K.
Auquier, P.
Verger, P.
Villani, P.
Honore, S.
Daumas, A.
author_facet Correard, F.
Montaleytang, M.
Costa, M.
Astolfi, M.
Baumstarck, K.
Loubière, S.
Amichi, K.
Auquier, P.
Verger, P.
Villani, P.
Honore, S.
Daumas, A.
author_sort Correard, F.
collection PubMed
description BACKGROUND: Inappropriate drug prescribing causes preventable drug-related adverse events that result in increased morbidity and mortality, additional costs and diminished quality of life. Numerous initiatives have been launched to improve the quality of drug prescribing and safeguard the security of drug administration processes in nursing homes. Against the backdrop of implementation of telemedicine services, the focus of the present work is to evaluate the impact of a telemedication review carried out by a hospital physician and pharmacist as part of the telemedicine offer. METHODS: The present study is a randomized controlled clinical trial. A total of 364 patients will be randomized into two groups: (1) an experimental group (182 patients) benefiting from a telemedication review using tele-expertise and (2) a control group (182 patients) receiving standard care. The primary endpoint will be rate of all-cause unplanned hospital admissions occurring within 3 months of randomization. The secondary endpoints will be rate of unplanned admissions at 6 months, patient quality of life, incidence of behavioral disturbances, number of falls, number of residents prescribed at least one inappropriate medication, nursing staff satisfaction, proposed medication reviews and their acceptability rate, characteristics of patients whose general practitioners have taken account of tele-expertise, efficacy of tele-expertise as compared to standard prescription and acceptability and satisfaction surveys of participating caregivers. DISCUSSION: In the literature, various studies have investigated the utility of structured medication review processes, but outcome measures are heterogeneous, and results vary widely. Medication review can detect medication-related problems in many patients, but evidence of clinical impact is scant. Incremental cost-effectiveness ratios will be used to compare the cost and effectiveness of the experimental strategy and that of standard care. Our approach, involving the combination of an acceptability survey and a mixed-method (qualitative and quantitative) satisfaction survey, is particularly innovative. The results of this randomized trial are expected to confirm that medication review using tele-expertise has potential as a worthwhile care management strategy for nursing home residents. TRIAL REGISTRATION: Clinicaltrials.gov NCT03640845; registered August 21, 2018 (Clinicaltrials.gov NCT03640845).
format Online
Article
Text
id pubmed-7169005
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71690052020-04-23 Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): study protocol for a randomized controlled trial Correard, F. Montaleytang, M. Costa, M. Astolfi, M. Baumstarck, K. Loubière, S. Amichi, K. Auquier, P. Verger, P. Villani, P. Honore, S. Daumas, A. BMC Geriatr Study Protocol BACKGROUND: Inappropriate drug prescribing causes preventable drug-related adverse events that result in increased morbidity and mortality, additional costs and diminished quality of life. Numerous initiatives have been launched to improve the quality of drug prescribing and safeguard the security of drug administration processes in nursing homes. Against the backdrop of implementation of telemedicine services, the focus of the present work is to evaluate the impact of a telemedication review carried out by a hospital physician and pharmacist as part of the telemedicine offer. METHODS: The present study is a randomized controlled clinical trial. A total of 364 patients will be randomized into two groups: (1) an experimental group (182 patients) benefiting from a telemedication review using tele-expertise and (2) a control group (182 patients) receiving standard care. The primary endpoint will be rate of all-cause unplanned hospital admissions occurring within 3 months of randomization. The secondary endpoints will be rate of unplanned admissions at 6 months, patient quality of life, incidence of behavioral disturbances, number of falls, number of residents prescribed at least one inappropriate medication, nursing staff satisfaction, proposed medication reviews and their acceptability rate, characteristics of patients whose general practitioners have taken account of tele-expertise, efficacy of tele-expertise as compared to standard prescription and acceptability and satisfaction surveys of participating caregivers. DISCUSSION: In the literature, various studies have investigated the utility of structured medication review processes, but outcome measures are heterogeneous, and results vary widely. Medication review can detect medication-related problems in many patients, but evidence of clinical impact is scant. Incremental cost-effectiveness ratios will be used to compare the cost and effectiveness of the experimental strategy and that of standard care. Our approach, involving the combination of an acceptability survey and a mixed-method (qualitative and quantitative) satisfaction survey, is particularly innovative. The results of this randomized trial are expected to confirm that medication review using tele-expertise has potential as a worthwhile care management strategy for nursing home residents. TRIAL REGISTRATION: Clinicaltrials.gov NCT03640845; registered August 21, 2018 (Clinicaltrials.gov NCT03640845). BioMed Central 2020-04-20 /pmc/articles/PMC7169005/ /pubmed/32312242 http://dx.doi.org/10.1186/s12877-020-01546-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Correard, F.
Montaleytang, M.
Costa, M.
Astolfi, M.
Baumstarck, K.
Loubière, S.
Amichi, K.
Auquier, P.
Verger, P.
Villani, P.
Honore, S.
Daumas, A.
Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): study protocol for a randomized controlled trial
title Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): study protocol for a randomized controlled trial
title_full Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): study protocol for a randomized controlled trial
title_fullStr Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): study protocol for a randomized controlled trial
title_full_unstemmed Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): study protocol for a randomized controlled trial
title_short Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): study protocol for a randomized controlled trial
title_sort impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (tem-ehpad): study protocol for a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169005/
https://www.ncbi.nlm.nih.gov/pubmed/32312242
http://dx.doi.org/10.1186/s12877-020-01546-3
work_keys_str_mv AT correardf impactofmedicationreviewviateleexpertiseonunplannedhospitalizationsat3monthsofnursinghomespatientstemehpadstudyprotocolforarandomizedcontrolledtrial
AT montaleytangm impactofmedicationreviewviateleexpertiseonunplannedhospitalizationsat3monthsofnursinghomespatientstemehpadstudyprotocolforarandomizedcontrolledtrial
AT costam impactofmedicationreviewviateleexpertiseonunplannedhospitalizationsat3monthsofnursinghomespatientstemehpadstudyprotocolforarandomizedcontrolledtrial
AT astolfim impactofmedicationreviewviateleexpertiseonunplannedhospitalizationsat3monthsofnursinghomespatientstemehpadstudyprotocolforarandomizedcontrolledtrial
AT baumstarckk impactofmedicationreviewviateleexpertiseonunplannedhospitalizationsat3monthsofnursinghomespatientstemehpadstudyprotocolforarandomizedcontrolledtrial
AT loubieres impactofmedicationreviewviateleexpertiseonunplannedhospitalizationsat3monthsofnursinghomespatientstemehpadstudyprotocolforarandomizedcontrolledtrial
AT amichik impactofmedicationreviewviateleexpertiseonunplannedhospitalizationsat3monthsofnursinghomespatientstemehpadstudyprotocolforarandomizedcontrolledtrial
AT auquierp impactofmedicationreviewviateleexpertiseonunplannedhospitalizationsat3monthsofnursinghomespatientstemehpadstudyprotocolforarandomizedcontrolledtrial
AT vergerp impactofmedicationreviewviateleexpertiseonunplannedhospitalizationsat3monthsofnursinghomespatientstemehpadstudyprotocolforarandomizedcontrolledtrial
AT villanip impactofmedicationreviewviateleexpertiseonunplannedhospitalizationsat3monthsofnursinghomespatientstemehpadstudyprotocolforarandomizedcontrolledtrial
AT honores impactofmedicationreviewviateleexpertiseonunplannedhospitalizationsat3monthsofnursinghomespatientstemehpadstudyprotocolforarandomizedcontrolledtrial
AT daumasa impactofmedicationreviewviateleexpertiseonunplannedhospitalizationsat3monthsofnursinghomespatientstemehpadstudyprotocolforarandomizedcontrolledtrial